• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发和验证老年局部晚期乳腺癌的生存预测模型和风险分层。

Development and Validation a Survival Prediction Model and a Risk Stratification for Elderly Locally Advanced Breast Cancer.

机构信息

Department of Radiotherapy, The First Affiliated Hospital of Weifang Medical College, Weifang, Shandong, China; Department of Radiotherapy, Weifang People's Hospital, Weifang, Shandong, China.

Department of Radiotherapy, The First Affiliated Hospital of Weifang Medical College, Weifang, Shandong, China; Department of Radiotherapy, Weifang People's Hospital, Weifang, Shandong, China.

出版信息

Clin Breast Cancer. 2022 Oct;22(7):681-689. doi: 10.1016/j.clbc.2022.06.002. Epub 2022 Jun 26.

DOI:10.1016/j.clbc.2022.06.002
PMID:35853792
Abstract

PURPOSE

we aimed to develop an individualized survival prediction model for elderly locally advanced breast cancer (LABC) and stratify its risk to assist in the treatment and follow-up of patients.

METHODS

Elderly LABC data were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. The best model was screened using Cox, least absolute shrinkage and selection operator (LASSO) and best subset regression to construct the nomogram. After internal and external validation of this model, risk stratification was established, and differences between risk groups were assessed using Kaplan-Meier method.

RESULTS

A total of 10,697 elderly LABC patients were divided into a training group (n = 7131) and a validation group (n = 3566) with a 5-year overall survival rate of 57.6% [confidence interval (CI): 56.4%-58.7%]. A nomogram was developed using age, marital status, histological grading, estrogen and progesterone receptors, surgery, radiation therapy, and chemotherapy as predictors. This model was evaluated and validated to perform well, with a discrimination index of 0.744 (95% CI: 0.734-0.753). Patients were divided into low, medium and high groups based on risk scores, and there was a significant difference in survival between the 3 groups.

CONCLUSION

The prognosis of elderly LABC was poor. The nomogram constructed based on prognostic factors could accurately predict the prognosis, which would provide a reference for treatment and follow-up.

摘要

目的

我们旨在为老年局部晚期乳腺癌(LABC)患者开发一种个体化生存预测模型,并对其风险进行分层,以协助患者的治疗和随访。

方法

从监测、流行病学和最终结果(SEER)数据库中提取老年 LABC 数据。使用 Cox、最小绝对收缩和选择算子(LASSO)和最佳子集回归筛选最佳模型,以构建列线图。对该模型进行内部和外部验证后,建立风险分层,并使用 Kaplan-Meier 方法评估风险组之间的差异。

结果

共纳入 10697 例老年 LABC 患者,分为训练组(n=7131)和验证组(n=3566),5 年总生存率为 57.6%(置信区间:56.4%-58.7%)。使用年龄、婚姻状况、组织学分级、雌激素和孕激素受体、手术、放疗和化疗作为预测因子,建立了一个列线图。该模型经过评估和验证,表现良好,区分度指数为 0.744(95%置信区间:0.734-0.753)。根据风险评分将患者分为低、中、高组,3 组间生存差异有统计学意义。

结论

老年局部晚期乳腺癌的预后较差。基于预后因素构建的列线图可以准确预测预后,为治疗和随访提供参考。

相似文献

1
Development and Validation a Survival Prediction Model and a Risk Stratification for Elderly Locally Advanced Breast Cancer.开发和验证老年局部晚期乳腺癌的生存预测模型和风险分层。
Clin Breast Cancer. 2022 Oct;22(7):681-689. doi: 10.1016/j.clbc.2022.06.002. Epub 2022 Jun 26.
2
Conditional survival nomogram predicting real-time prognosis of locally advanced breast cancer: Analysis of population-based cohort with external validation.基于人群的队列研究并外部验证:预测局部晚期乳腺癌实时预后的条件生存列线图。
Front Public Health. 2022 Oct 31;10:953992. doi: 10.3389/fpubh.2022.953992. eCollection 2022.
3
Development and validation of nomograms for predicting overall survival and cancer specific survival in locally advanced breast cancer patients: A SEER population-based study.基于 SEER 人群的研究:预测局部晚期乳腺癌患者总生存和癌症特异性生存的列线图的建立和验证。
Front Public Health. 2022 Sep 20;10:969030. doi: 10.3389/fpubh.2022.969030. eCollection 2022.
4
Survival Nomogram for Patients With Locally Advanced Breast Cancer Undergoing Immediate Breast Reconstruction: A SEER Population-Based Study.局部晚期乳腺癌即刻乳房重建患者的生存列线图:一项 SEER 人群研究。
Clin Breast Cancer. 2023 Jun;23(4):e219-e229. doi: 10.1016/j.clbc.2023.02.008. Epub 2023 Feb 21.
5
Bladder cancer survival nomogram: Development and validation of a prediction tool, using the SEER and TCGA databases.膀胱癌生存列线图:利用监测、流行病学和最终结果(SEER)数据库及癌症基因组图谱(TCGA)数据库开发并验证一种预测工具
Medicine (Baltimore). 2019 Nov;98(44):e17725. doi: 10.1097/MD.0000000000017725.
6
A competing-risk nomogram to predict cause-specific death in elderly patients with colorectal cancer after surgery (especially for colon cancer).用于预测老年结直肠癌(尤其是结肠癌)术后患者特定原因死亡的竞争风险列线图。
World J Surg Oncol. 2020 Feb 4;18(1):30. doi: 10.1186/s12957-020-1805-3.
7
Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Young Patients with Epithelial Ovarian Cancer: Analysis Based on SEER Program.基于 SEER 计划的上皮性卵巢癌年轻患者总生存和癌症特异性生存的预测列线图分析。
Adv Ther. 2022 Jan;39(1):257-285. doi: 10.1007/s12325-021-01955-9. Epub 2021 Oct 29.
8
Nomogram predicting overall survival of rectal squamous cell carcinomas patients based on the SEER database: A population-based STROBE cohort study.基于监测、流行病学和最终结果(SEER)数据库预测直肠鳞状细胞癌患者总生存期的列线图:一项基于人群的加强观察性研究报告(STROBE)队列研究
Medicine (Baltimore). 2019 Nov;98(46):e17916. doi: 10.1097/MD.0000000000017916.
9
Survival Nomogram for Young Breast Cancer Patients Based on the SEER Database and an External Validation Cohort.基于 SEER 数据库和外部验证队列的年轻乳腺癌患者生存列线图
Ann Surg Oncol. 2022 Sep;29(9):5772-5781. doi: 10.1245/s10434-022-11911-8. Epub 2022 Jun 3.
10
Nomogram for predicting overall survival in stage II-III colorectal cancer.预测 II-III 期结直肠癌总生存期的列线图。
Cancer Med. 2020 Apr;9(7):2363-2371. doi: 10.1002/cam4.2896. Epub 2020 Feb 6.

引用本文的文献

1
Log odds of positive lymph nodes (LODDS)-based novel nomogram for survival estimation in patients with invasive micropapillary carcinoma of the breast.基于对数优势比阳性淋巴结(LODDS)的新型列线图,用于评估乳腺浸润性微乳头状癌患者的生存估计。
BMC Med Res Methodol. 2024 Apr 18;24(1):90. doi: 10.1186/s12874-024-02218-1.
2
A scoping review of web-based, interactive, personalized decision-making tools available to support breast cancer treatment and survivorship care.一项关于基于网络的交互式个性化决策工具的范围综述,这些工具可用于支持乳腺癌治疗及生存护理。
J Cancer Surviv. 2024 Mar 28. doi: 10.1007/s11764-024-01567-6.
3
Development and validation of nomograms for predicting overall survival and cancer specific survival in locally advanced breast cancer patients: A SEER population-based study.
基于 SEER 人群的研究:预测局部晚期乳腺癌患者总生存和癌症特异性生存的列线图的建立和验证。
Front Public Health. 2022 Sep 20;10:969030. doi: 10.3389/fpubh.2022.969030. eCollection 2022.